Objective. To assess the effect depression has on outcomes after cervical epidural steroid injections (CESIs). Design. Retrospective review of a prospectively collected database. Setting. Single institution tertiary care center. Subjects. Fifty-seven patients with cervical spondylosis and cervical radicular pain who were deemed appropriate surgical candidates but elected to undergo CESI first were included. Methods. Twenty-one of 57 (37%) patients with depression (defined as Zung Depression Scale >33) were included. Patient-reported outcomes including Neck Disability Index (NDI), numeric rating scale (NRS) for arm pain (AP), NRS for neck pain (NP), and EuroQol-5D (EQ-5D) were collected at baseline and three-month follow-up. Minimal clinically important differences were then calculated to provide dichotomous outcome measures of success. Results. Overall, 24 and 28 patients achieved at least 50% improvement in AP and NP, respectively. In terms of disability, 25/57 (43.9%) patients achieved >13.2-point improvement on the NDI overall. In patients with depression, 4/21 (19.0%) and 5/21 (23.8%) achieved at least 50% improvement on the NRS for AP and NP, respectively, compared with 20/36 (55.5%) and 23/36 (63.8%) in patients without depression. This difference was statistically significant for both pain measures (P < 0.002 AP, P < 0.006 NP). Statistically fewer patients, 5/21 (24%), with depression achieved !13.2-point improvement on the NDI compared with 20/36 (55%) nondepressed patients (P < 0.01). There was no difference in outcomes between groups on the EQ-5D. Conclusions. Patients with cervical spondylosis and comorbid depression who undergo CESI are less likely to achieve successful outcomes in both pain and function compared with nondepressed patients at three months.
Introduction
Cervical disc herniation, stenosis, and spondylolisthesis are common pathologies of the cervical spine, often resulting in neck and cervical radicular pain. Cervical spine pathology is a global issue, with a lifetime prevalence of neck pain as high as 70% [1, 2] . More specifically, cervical radiculopathy has an age-adjusted incidence of 83.2 per 100,000 [3] . In the United States, cervical spine pathology is the fourth leading cause of disability [4] . Nonoperative modalities are the firstline treatment in the setting of cervical radiculopathy. In patients with cervical radicular pain, fluoroscopically guided cervical epidural steroid injections (CESIs) may be effective in easing pain and reducing the need for surgery [5, 6] . Historically, up to 75% of patients have good outcomes without the need for surgical management [7] .
CESI is a common nonoperative treatment with increasing rates of utilization over the past two decades. Between 2000 to 2011, there was an increase of 123% V C 2018 American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com and 142% per 100,000 Medicare beneficiaries for cervical/thoracic interlaminar and transforaminal epidural injections, respectively [8] . Between 2003 and 2007, Medicare payments for transforaminal epidural injections rose almost 150% from $57 million to $141 million [9] . Being able to recognize patient risk factors and comorbidities that may negatively or positively affect outcomes is a crucial component in delivering cost-effective care.
Psychological status and depression have been shown to significantly correlate with neck pain in the general population [10] [11] [12] . Depression, as a preoperative risk factor, is also negatively associated with outcomes in the surgical treatment of cervical spine disorders [13] [14] [15] [16] . However, no studies have attempted to analyze outcomes associated with nonsurgical management of cervical radiculopathy in patients with depression. Our goal was to assess the effect of depression on patient-reported outcomes (PROs) following CESI.
Methods
Patients were screened for the study from a prospective longitudinal web-based spine outcomes registry [17] . The registry included patients who presented to the comprehensive spine clinic at a single academic institution between January 2012 and January 2015. For representative sampling, a six-day enrollment cycle was adopted, and six patients were accrued during each enrollment cycle. Patients were enrolled into the registry only if they were felt to be surgical candidates, as determined by the treating surgeon. Based on imaging and exam, patients were diagnosed with herniated disc, spondylolisthesis, or stenosis as their primary diagnosis. Inclusion criteria were 1) patients age 18-70 years; 2) correlative imaging findings of structural degenerative pathology including disc herniation, stenosis (central, foraminal, or lateral recess), and spondylolisthesis; and 3) complaints of radiating arm pain. All eligible patients were amenable to surgical management but chose the route of cervical epidural steroid injection as an alternative method of treatment. Exclusion criteria were 1) exam or imaging findings of cervical myelopathy; 2) pathologic cause of spinal disease; 3) an active medical or workman's compensation lawsuit; 4) any extraspinal cause of neck and arm pain; 5) nonspecific cause of neck pain; 6) an unwillingness or inability to participate in follow-up procedures. Of the eligible patients, those with completed three-month follow-up were included in this study.
Patient demographics, clinical characteristics, clinical presentation, and procedure details were collected. Validated PROs for quality of life (EuroQol-5D [EQ-5D]), disability (Neck Disability Index [NDI]), and pain (numeric rating scale [NRS] for neck pain and arm pain [NP, AP]) were collected at baseline and three months after CESI through telephone interview by an independent investigator not involved in clinical care. Based on previously validated values, the Modified Zung-Depression scale (ZDS) was used as a screening tool for depression [18, 19] . Patients were dichotomized into nondepressed (ZDS scores 33) and depressed (>33) groups [19, 20] .
Mean and standard deviation for continuous variables and frequency for categorical variables were computed. Change-scores of PROs from baseline to three months were calculated. The Student t test was used to compare continuous variables, and the chi-square test was used to compare categorical variables. Ninety-five percent confidence intervals were also calculated for all categorical outcomes. Patient demographic and procedure variables were compared between depressed and nondepressed patients. Mean baseline PROs, absolute PRO scores at three months, and change-scores were compared between depressed and nondepressed patients. Proportion of patients who achieved at least 50% improvement in NRS-NP and -AP were calculated. Clinically meaningful improvement was defined using the concept of minimal clinically important difference (MCID). The MCID threshold was derived using the previously reported minimal detectable change approach, which defines MCID as the upper limit of the 95% confidence interval for the mean change-score in the group described as nonresponders [21] . MCIDs were calculated for the PROs: NDI: 13.2 points; EQ-5D: 0.20 quality-adjusted lifeyears gained; NP: 2.1 points; and AP: 2.1 points. Patients in both the depressed and nondepressed groups who achieved MCID for all PROs were compared. Patients in both the depressed and nondepressed groups who achieved 50% improvement in NRS-NP and -AP were also compared. Approval for the study and a waver of informed consent were obtained from the institutional review board (IRB) for all the patients entered into the registry. All analyses were tested at the 0.05 level of significance. The analysis was performed using SPSS, version 20 (IBM Inc., Chicago, IL, USA).
Results
A total of 57 patients met eligibility criteria for analysis (Table 1) . Twenty-one (37%) patients were categorized as depressed based on ZDS scores, with a mean age of 62.6 6 11.3 years. Thirty-six (63%) patients were categorized as nondepressed, with a mean age of 58.5 6 12.3 years (P ¼ 0.22). There was a significant difference in terms of sex, with the depressed group having a higher proportion of females (14 [67%] vs 14 [39%], P ¼ 0.03). There were no significant differences in clinical comorbidities between the groups, including smoking status, diabetes, or hypertension. Both groups had no significant differences in proportion of patients who attempted bracing or physical therapy before injection treatment. No significant differences were seen in terms of the primary diagnosis between the two treatment groups. The two treatment groups had no significant differences with regards to number of injections or number of levels treated per patient.
Depressed patients had significantly worse baseline PROs compared with nondepressed patients for NDI (P ¼ 0.002), EQ-5D (P < 0.0001), and NRS-AP (P ¼ 0.04) ( Table 1) . Baseline NRS-NP was worse in depressed patients compared with nondepressed patients; however, this did not reach statistical significance (P ¼ 0.07). All patients demonstrated significant improvement in PRO scores from baseline to three months: NDI: 37.9 6 14.3 vs 28.9 6 20.2 (P < 0.0001); EQ-5D: 0.66 6 0.19 vs 0.76 6 0.18 (P < 0.0001); NRS-NP: 6.3 6 1.8 vs 3.9 6 2.6 (P < 0.0001); NRS-AP: 4.7 6 3.4 vs 2.4 6 3.0 (P < 0.0001). The mean absolute scores for all PROs at three months were significantly worse in the depressed vs nondepressed patients ( Table 2 ). The depressed patients had significantly lower mean changescores for NDI (P ¼ 0.008) and NRS-NP (P ¼ 0.04). Similarly, the depressed patients did not have as much clinically meaningful improvement in NDI (24% vs 56%, P ¼ 0.01) and NRS-NP (29% vs 64%, P ¼ 0.02) as nondepressed patients.
Overall, 24 (42.1%, 95% CI þ/À 12.8%) and 28 (49.1%, 95% CI þ/À13.0%) patients achieved at least 50% improvement in AP and NP, respectively. In terms of disability, 25/57 (43.9%, 95% CI þ/À 12.9%) patients achieved >13.2-point improvement on the NDI overall. In patients with depression, 4/21 (19.0%, 95% CI þ/À 16.8%) and 5/21(23.8%, 95% CI þ/À 18.2%) achieved at least 50% improvement on the NRS for AP and NP, respectively, compared with 20/36 (55.5%, 95% CI þ/À 16.2%) and 23/36 (63.9%, 95% CI þ/À 15.7%) in patients without depression (Table 2) . This difference was statistically significant for both pain measures (nonoverlapping 95% CI, P ¼ 0.002 AP, P ¼ 0.006 NP). Statistically fewer patients, 5/21 (24%, 95% CI þ/À 18%), with depression achieved !13.2-point improvement on the NDI, compared with 20/36 (55%, 95% CI þ/À16%) nondepressed patients (95% CI overlapping, P < 0.01) ( Table 3 ). There was no difference in outcomes between groups on EQ-5D. 
Discussion
In this study, we set out to determine the effect of depression on PROs following CESI for cervical radiculopathy. Patients with depressive symptoms had lower baseline PROs compared with nondepressed patients, with the exception of NRS-NP. They also had lower overall threemonth PROs after CESI for all PROs. Depressed patients did not have successful outcomes with CESI as categorically defined by achieving minimally clinical meaningful improvement on the NDI or NRS-NP, compared with nondepressed patients. By using a more rigorous definition of successful outcome based on NRS (at least 50% improvement), depressed patients also were less likely to achieve successful outcomes for both arm pain and neck pain (Table 3 ). Our study demonstrates that patients with depressive symptoms are statistically less likely to achieve clinically meaningful outcomes in both pain and disability compared with nondepressed patients.
Depression as a patient risk factor has been extensively studied in the lumbar spine literature and has been associated with worse outcomes in both operative and nonoperative treatments [22] [23] [24] [25] [26] [27] [28] . Although less studied in the cervical spine literature, depression as a preoperative risk factor has been shown to be negatively associated with outcomes in surgical treatment of cervical spine disorders in select studies as well [13] [14] [15] [16] . No studies previously have attempted to analyze outcomes associated with nonsurgical management of cervical radiculopathy in patients with depression. Our study provides supporting evidence that patients with depression have worse outcomes in the treatment of cervical spine disease even with medical modalities.
The treatment of psychological disease such as depression in patients with cervical pathology warrants attention as this may underpin why these patients have less successful outcomes with more invasive treatment options. In a previous analysis performed by Sinikallio et al. [29] , they determined that patients who underwent lumbar surgery were found to have poorer outcomes if they were also depressed. However, in a subsequent twoyear follow-up analysis, those patients who recovered from depression were found to have outcomes equivalent to patients without concomitant psychological illness. These findings support the importance of treating concomitant depression instead of solely focusing on the spinal pathology itself. Although depression is an important risk factor for worse outcomes in spinal diseases, it is certainly modifiable through appropriate treatment.
We analyzed improvement in NP after CESI as these data were readily available, even though CESI is most commonly indicated for the treatment of radicular pain. It is unique that this study found overall improvements in NP to be very similar to improvements in AP (24/57 [42.1%] and 28/57 [49.1%], respectively). Interestingly, by all rigors of measure (2.1-point NRS improvement, 50% NRS improvement, t test, 95% CI), there was a difference favoring outcomes related to NP in those without depression compared with those with depression. The fact that the difference in Oswestry Disability Index outcomes was significant on t test and not by overlapping confidence intervals was possibly due to insufficient sample size. However, for 50% improvement in AP and NP, statistical significance held for both t test and 95% confidence intervals.
There are a few limitations that need to be recognized within our study design. First, follow-up with PROs was only recorded up to three months after epidural injection. It is possible that longer-term outcomes may not differ between depressed and nondepressed groups when treated by CESI. However, the systemic physiologic effects of steroids would no longer be expected even at three months, so any differences or lack thereof later on are not likely related to the ESI itself. Furthermore, a majority of our patients did not attempt physical therapy before injections, which could have ultimately influenced our outcome scores and also may not be representative of practice trends at other institutions. Another limitation is that while some patients were found to have depressive symptoms based on ZDS scores, some patients were not formally diagnosed and therefore were not actively being treated. To better assess how depression can affect outcomes, we would need to stratify the depressed group into those who were formally diagnosed and those who were actively being treated. These mitigating factors may be related to the lack of difference in outcomes on the EQ-5D as quality of life is a multifactorial outcome measure.
Conclusion
Concomitant depressive psychological symptoms are associated with less likelihood of successful outcomes after CESI with respect to both pain and function. Although as a whole the group with depression still showed overall improvement at three months, only a few experienced clinically meaningful benefit from CESI. This highlights the importance of addressing and considering comorbid depression in patients with cervical spondylosis when considering CESI, as this may have the potential to improve outcomes in this population.
